The Sacroiliitis Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Sacroiliitis Treatment Market?
The size of the sacroiliitis treatment market has significantly expanded in recent years. It is forecasted to increase from $1.64 billion in 2024 to $1.77 billion in 2025, with a compound annual growth rate of 7.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Sacroiliitis Treatment Industry?
The Sacroiliitis Treatment Global Market is predicted to grow to a value of $2.33 billion by 2029, projecting a compound annual growth rate (CAGR) of 7.2%.
Download Your Free Sample of the 2025 Sacroiliitis Treatment Market Report and Uncover Key Trends Now!
Global Market Segmentation: Identifying Major Sacroiliitis Treatment Industry Segments
The sacroiliitis treatment market covered in this report is segmented –
1) By Type: Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, Electrical Stimulation
2) By Diagnosis: Imaging Tests, Physical Examination, Laboratory Tests, Other Diagnosis
3) By Route Of Administration: Oral, Injectable, Topical
4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings
What are the Key Growth Drivers Fueling the Sacroiliitis Treatment Market?
The key drivers in the sacroiliitis treatment marketare:
• Increasing investment in research and development for novel therapeutics
• Rising adoption of telemedicine for chronic pain management
• A rise in autoimmune disease incidence and availability of targeted biologic therapies
• Rising demand for personalized medicine approaches and advancements in targeted drug delivery systems
Pre-order the 2025 Sacroiliitis Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Sacroiliitis Treatment Market?
The key trends in the sacroiliitis treatment market are:
• The development of targeted drug delivery systems is an emerging trend in the Sacroiliitis treatment market.
• Personalized treatment approaches are shaping the future of the market.
• Innovation in regenerative medicine therapies is a significant trend.
• The market is influenced by advancements in robotic-assisted surgical procedures.
Who Are the Top Competitors & Leading Players in the Sacroiliitis Treatment Market?
Major companies in the sacroiliitis treatment market are:
• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Novartis AG
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Amgen Inc.
• Biogen Inc.
• Sandoz Group AG
• UCB S.A.
• Hikma Pharmaceuticals PLC
• Samsung Bioepis Co. Ltd.
• Lupin Limited
• Zydus Lifesciences Limited
• Celltrion Healthcare Co. Ltd.
• Torrent Pharmaceuticals Limited
• Globus Medical
• Fortis Healthcare
• Orthofix Medical Inc.
• Coherus BioSciences Inc.
• SI-BONE Inc.
Regional Dominance: Which Area Leads the Global Sacroiliitis Treatment Market?
North America was the largest region in the sacroiliitis treatment market in 2024
